
Paige Kingston
Dermatology Residency · Indiana University School of Medicine
Credentials: ·
History
- 2025–Present
- 2024–2025
Preliminary or Transitional Year

Research
Deucravacitinib: a novel TYK2 inhibitor for the treatment of moderate-to-severe psoriasis
Journal of Psoriasis and Psoriatic Arthritis · 2023 · First of 4 authors · 25 citations
Journal of the American Academy of Dermatology · 2024 · 16 citations
Journal of the American Academy of Dermatology · 2023 · 16 citations

20 papers

16 papers · 16 as a fellow

14 papers · 14 as a resident

13 papers · 1 as a resident

13 papers · 8 as a resident
- AH
2 papers · 1 as a resident

2 papers · 2 as a resident

2 papers · 1 as a resident


